Skip to main content
. 2002 Jul;54(1):51–58. doi: 10.1046/j.1365-2125.2002.01611.x

Table 2.

Mean treatment differences between levocetirizine (or diphenhydramine) and placebo with 95% CI at 1, 2 or 3 h time point for the main trial tests, at day 1 and day 5.

Levocetirizine 5 mg Diphenhydramine 50 mg
Test 1 h 2 h 3 h 1 h 2 h 3 h
Day 1
 CFF (Hz) −0.15 −0.08 −0.81 −1.04 −1.14 −1.62
(−1.15, 0.84) (−1.07, 0.92) (−1.80, 0.19) (−2.03, −0.06) (−2.13, −0.16) (−2.61, −0.64)
 CRT (ms) −11.06 −7.33 0.22 8.50 10.00 15.22
(−30.32, 8.21) (−31.78, 17.11) (−21.08, 21.53) (−12.76, 29.76) (−9.09, 29.09) (−2.55, 32.99)
 BS Distance displ. (cm) 3.26 2.42 6.19 7.35 7.99 16.35
 Eyes closed (−1.90, 8.41) (−9.11, 13.94) (−1.27, 13.64) (−0.81, 15.50) (−4.52, 20.50) (5.61, 27.10)
 LMT immediate recall ND 0.61 ND ND −0.61 ND
(−1.57, 2.80) (−1.93, 0.71)
 VAS Alertness score −3.78 −4.47 −7.87 −4.88 −13.51 −17.09
(−14.04, 6.48) (−12.19, 3.25) (−15.15, −0.60) (−18.04, 8.27) (−26.09, −0.92) (−29.89, −4.28)
Day 5
 CFF (Hz) −0.18 0.16 0.15 0 −0.17 −0.63
(−0.91, 0.54) (−0.74, 1.06) (−0.56, 0.86) (−1.09, 1.09) (−1.27, 0.94) (−1.69, 0.43)
 CRT (ms) 1.00 −8.22 −2.11 6.72 11.11 12.17
(−14.97, 16.97) (−30.45, 14.00) (−20.15, 15.93) (−4.93, 18.38) (−6.06, 28.28) (−2.09, 26.42)
 BS Distance displ. (cm) 6.62 5.73 6.42 1.63 4.61 4.97
 Eyes closed (−2.20, 15.43) (−3.96, 15.42) (−2.08, 14.93) (−6.08, 9.33) (−2.35, 11.56) (−3.58, 13.32)
 LMT immediate recall ND −0.06 ND ND −0.56 ND
(−1.38, 1.27) (−0.94, 2.05)
 VAS 0.77 7.19 5.47 0.31 −5.12 −4.20
 Alertness score (−4.17, 5.71) (−1.12, 15.50) (−2.49, 13.43) (−8.82, 9.44) (−13.61, 3.38) (−12.55, 4.15)

ND:Not done.